SCHEMBL77196

SCHEMBL77196

O=C(O)c1ccc(Cl)s1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL900899 0.98 DAO (0.95)
SCHEMBL7373354 0.89 DAO (0.80)
Alcohol SCHEMBL28225514 0.89 DAO (0.80)
Acetonitrile SCHEMBL27744525 0.88 DAO (0.77)
SCHEMBL3741825 0.87 DAO (0.76)
SCHEMBL9144815 0.82 F2 (0.70)
SCHEMBL7041130 0.81 DAO (0.68)
SCHEMBL70493 0.81 DAO (0.67)
SCHEMBL17088064 0.80
SCHEMBL92875 0.80

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2198 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119425797-A Preparation of low-density vermiculite-based nano zero-valent limited-domain ferro-manganese complex and application thereof in advanced treatment of novel pollutants 合肥大学 2025-02-14 CN claimed
CN-119241583-A Organic-inorganic hybrid { Zr6Sn4Crystalline tin-zirconium-oxygen cluster patterning material and preparation method and application thereof 中国科学院福建物质结构研究所 2025-01-03 CN claimed
CN-118791648-B Thiophene group-containing chitosan and preparation method and application thereof 中国科学院烟台海岸带研究所 2024-11-26 CN claimed
CN-118983613-A Method for constructing modified diaphragm and lithium-sulfur battery based on metal organic frame defects 陕西科技大学 2024-11-19 CN claimed
CN-116212949-B Ferric iron complex and preparation method and application thereof 南京大学 2024-06-21 CN claimed
CN-115557928-B Synthesis method of 2-chlorothiophene-5-formic acid 浙江燎原药业有限公司 2024-03-19 CN claimed
CN-112110910-B Method for preparing rivaroxaban intermediate and method for preparing rivaroxaban from rivaroxaban intermediate 上海特化医药科技有限公司 2024-03-19 CN claimed
CN-116941616-A Application of narinone derivative in preparing medicine for preventing and treating plant pathogenic fungi 贵州省天然产物研究中心 2023-10-27 CN claimed
CN-116212949-A Ferric iron complex and preparation method and application thereof 南京大学 2023-06-06 CN claimed
CN-115894471-A Synthetic method of rivaroxaban 南京工业大学 2023-04-04 CN claimed
JP-2002501024-A 2002-01-15 JP claimed
EP-1086099-A4 SULFONIC ACID OR SULFONYLAMINO N-(HETEROARALKYL)-AZAHETEROCYCLYLAMIDE COMPOUNDS AVENTIS PHARM PROD INC (US) 2002-01-02 EP claimed
WO-2001098272-A1 NOVEL COMPOUNDS ASTRAZENECA AB (SE) 2001-12-27 WO claimed
EP-1140901-A2 SUBSTITUTED (AMINOIMINOMETHYL OR AMINOMETHYL)BENZOHETEROARYL COMPOUNDS AS FACTOR XA INHIBITORS Aventis Pharmaceuticals Products Inc. (US) 2001-10-10 EP claimed
US-6281227-B1 INHIBITORS OF THE ACTIVITY OF FACTOR XA. AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2001-08-28 US claimed
EP-1086099-A1 SULFONIC ACID OR SULFONYLAMINO N-(HETEROARALKYL)-AZAHETEROCYCLYLAMIDE COMPOUNDS Aventis Pharmaceuticals Products Inc. (US) 2001-03-28 EP claimed
EP-1051176-A1 SUBSTITUTED OXOAZAHETEROCYCLYL FACTOR Xa INHIBITORS Aventis Pharmaceuticals Products Inc. (US) 2000-11-15 EP claimed
WO-2000039087-A2 SUBSTITUTED (AMINOIMINOMETHYL OR AMINOMETHYL)BENZOHETEROARYL COMPOUNDS AS FACTOR XA INHIBITORS AVENTIS PHARMACEUTICALS PRODUCTS INC. (US) 2000-07-06 WO claimed
WO-1999062904-A1 SULFONIC ACID OR SULFONYLAMINO N-(HETEROARALKYL)-AZAHETEROCYCLYLAMIDE COMPOUNDS AVENTIS PHARMACEUTICALS PRODUCTS INC. (US) 1999-12-09 WO claimed
WO-1999037304-A1 SUBSTITUTED OXOAZAHETEROCYCLYL FACTOR Xa INHIBITORS AVENTIS PHARMACEUTICALS PRODUCTS INC. (US) 1999-07-29 WO claimed